{
    "clinical_study": {
        "@rank": "55232", 
        "arm_group": {
            "arm_group_label": "Photo Acoustic Imaging", 
            "arm_group_type": "Experimental", 
            "description": "An exploratory, single armed, pilot study designed to evaluate the feasibility of Photo Acoustic Imaging (PAI) in a clinical setting."
        }, 
        "brief_summary": {
            "textblock": "After locating the suspicious lesion/mass with standard of care mammography and/or\n      ultrasound, a photoacoustic scan will be performed in the breast where the lesion is\n      located. After the PA scan a biopsy will be performed, if clinically indicated (based on the\n      mammogram and ultrasound only)."
        }, 
        "brief_title": "Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients must have a breast lesion/mass found at physical examination, mammography or\n             ultrasound (US), that has not been surgically resected\n\n          -  Patients may have any of the following characteristics:\n\n               -  Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer\n                  Tamoxifen)\n\n               -  Breast implants\n\n               -  Previous breast biopsy\n\n               -  Previous breast surgery\n\n               -  Previous breast cancer\n\n               -  High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA)\n                  mutations, other gynecologic cancer)\n\n          -  Ability to understand and the willingness to sign a written informed consent document\n\n        Exclusion Criteria:\n\n          -  Patients who have had primary surgical excision of the suspicious finding\n\n          -  Pregnant or lactating women"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01780532", 
            "org_study_id": "BRS0018", 
            "secondary_id": [
                "SU-09022011-8372", 
                "21623"
            ]
        }, 
        "intervention": {
            "arm_group_label": "Photo Acoustic Imaging", 
            "description": "Standard of Care", 
            "intervention_name": "Photoacoustic Imaging (PAI)", 
            "intervention_type": "Procedure", 
            "other_name": "Hand held photoacoustic probe"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "October 11, 2013", 
        "location": {
            "contact": {
                "email": "ccto-office@stanford.edu", 
                "last_name": "Stanford Cancer Clinical Trials Office, MD", 
                "phone": "650-498-7061"
            }, 
            "facility": {
                "address": {
                    "city": "Stanford", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94305"
                }, 
                "name": "Stanford University Cancer Institute"
            }, 
            "investigator": {
                "last_name": "Sanjiv Gambhir, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study", 
        "overall_official": {
            "affiliation": "Stanford University", 
            "last_name": "Sanjiv Gambhir, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The lesion visibility on PAI, described using a five-level scale: 1. Not visible 2. Barely visible 3. Fair (or moderately visible) 4. Visible 5. Clearly visible.", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01780532"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Measures of hypoxia in the lesion", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Stanford University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}